Exelixis
EXEL
#1763
Rank
NZ$20.67 B
Marketcap
NZ$76.82
Share price
-0.25%
Change (1 day)
21.10%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company